Baidu
map

不明原因的栓塞性卒中和心源性卒中之间有什么关系?

2021-07-21 MedSci原创 MedSci原创

不明原因的栓塞性卒中和心源性卒中之间有什么关系?-第四个问题

《梅斯直播课:心源性卒中诊断评估及治疗策略》

回答问题4:不明原因的栓塞性卒中和心源性卒中之间有什么关系?

 

欢迎点赞、评论、分享

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220769, encodeId=33c21220e69a3, content=<a href='/topic/show?id=16b05108159' target=_blank style='color:#2F92EE;'>#心源性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51081, encryptionId=16b05108159, topicName=心源性卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Wed May 18 21:40:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536292, encodeId=76f315362923e, content=<a href='/topic/show?id=87ec6201043' target=_blank style='color:#2F92EE;'>#栓塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62010, encryptionId=87ec6201043, topicName=栓塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a5012676127, createdName=jiekemin, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593539, encodeId=8a60159353943, content=<a href='/topic/show?id=9850510e9a3' target=_blank style='color:#2F92EE;'>#心源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51079, encryptionId=9850510e9a3, topicName=心源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=955718147815, createdName=mhm295, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026918, encodeId=d4131026918ce, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jul 21 19:29:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1220769, encodeId=33c21220e69a3, content=<a href='/topic/show?id=16b05108159' target=_blank style='color:#2F92EE;'>#心源性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51081, encryptionId=16b05108159, topicName=心源性卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Wed May 18 21:40:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536292, encodeId=76f315362923e, content=<a href='/topic/show?id=87ec6201043' target=_blank style='color:#2F92EE;'>#栓塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62010, encryptionId=87ec6201043, topicName=栓塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a5012676127, createdName=jiekemin, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593539, encodeId=8a60159353943, content=<a href='/topic/show?id=9850510e9a3' target=_blank style='color:#2F92EE;'>#心源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51079, encryptionId=9850510e9a3, topicName=心源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=955718147815, createdName=mhm295, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026918, encodeId=d4131026918ce, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jul 21 19:29:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1220769, encodeId=33c21220e69a3, content=<a href='/topic/show?id=16b05108159' target=_blank style='color:#2F92EE;'>#心源性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51081, encryptionId=16b05108159, topicName=心源性卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Wed May 18 21:40:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536292, encodeId=76f315362923e, content=<a href='/topic/show?id=87ec6201043' target=_blank style='color:#2F92EE;'>#栓塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62010, encryptionId=87ec6201043, topicName=栓塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a5012676127, createdName=jiekemin, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593539, encodeId=8a60159353943, content=<a href='/topic/show?id=9850510e9a3' target=_blank style='color:#2F92EE;'>#心源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51079, encryptionId=9850510e9a3, topicName=心源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=955718147815, createdName=mhm295, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026918, encodeId=d4131026918ce, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jul 21 19:29:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-23 mhm295
  4. [GetPortalCommentsPageByObjectIdResponse(id=1220769, encodeId=33c21220e69a3, content=<a href='/topic/show?id=16b05108159' target=_blank style='color:#2F92EE;'>#心源性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51081, encryptionId=16b05108159, topicName=心源性卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Wed May 18 21:40:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536292, encodeId=76f315362923e, content=<a href='/topic/show?id=87ec6201043' target=_blank style='color:#2F92EE;'>#栓塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62010, encryptionId=87ec6201043, topicName=栓塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a5012676127, createdName=jiekemin, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593539, encodeId=8a60159353943, content=<a href='/topic/show?id=9850510e9a3' target=_blank style='color:#2F92EE;'>#心源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51079, encryptionId=9850510e9a3, topicName=心源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=955718147815, createdName=mhm295, createdTime=Fri Jul 23 07:29:51 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026918, encodeId=d4131026918ce, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jul 21 19:29:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关资讯

CNStroke2018丨中国心源性卒中的现状与发展——房颤与卒中的新进展

中国脑卒中大会,暨第八届全国心脑血管病论坛2018年5月3~6日在北京召开。现任国家心血管病中心、中国医学科学院阜外医院教授、博士生导师、心律失常诊治中心主任张澍教授,就中国目前心房颤动(房颤)与卒中诊断和治疗的新进展情况发表专题报告。

JAMA:预防心源性卒中的新方法-左心耳夹闭术

心脏外科手术是最常见的手术之一,在美国每年超过30万例冠脉搭桥手术(CABG)和瓣膜手术。许多心外科手术的患者,既往房颤病史会增加卒中的风险。在房颤患者中,左心耳血栓是心源性卒中的主要栓子来源,有时候外科手术中闭塞左心耳(occlusion of the left atrial appendage,LAAO)能够降低卒中的长期风险

Stroke:血栓中DNA含量可帮助识别不明原因栓塞性卒中包含的心源性卒中病例

血栓中DNA含量可能是一个准确的生物标志物,用于识别不明原因栓塞性AIS患者中的心源性卒中病例。

心源性卒中的治疗策略是什么?

心源性卒中的治疗策略是什么?-第一个问题

心源性卒中什么时候启动抗凝比较合适?

心源性卒中什么时候启动抗凝比较合适?-第二个问题

卵圆孔未闭封堵术能否作为心源性卒中的一级预防策略?

卵圆孔未闭封堵术能否作为心源性卒中的一级预防策略-第三个问题

拓展阅读

Stroke:未确定来源的栓塞性卒中患者具有高风险颈动脉斑块的特征

由此可见,在来源不明的栓塞性卒中患者中,具有高风险特征的斑块在同侧颈动脉中的患病率是对侧颈动脉的5倍,提示与卒中风险有关。

JAMA N:心房扩大的不明来源性栓塞性卒中应该抗凝治疗?

不明来源栓塞性卒中(Embolic strokesof undetermined source,ESUS) 占所有缺血性卒中的20%,每年复发率为3-6%。隐源性卒中(一个比较老的分类方式,包括 ESUS)的长期持续心电监测的研究发现3年内近30%的患者能够监测到房颤。因为口服抗凝剂史预防房颤相关卒中的最有效的方法,因此有理由相信经验性抗凝治疗能够降低 ESUS 患者的卒中复发。不过,NAVIGA

NEJM:不明来源栓塞性卒中,抗凝还是抗血小板?

大部分卒中为缺血性梗死,其病因分为:大动脉颅外或颅内动脉粥样硬化、心源性栓塞、小动脉闭塞和其他病因,以及少见病因。然而,20-30%的缺血性卒中为隐源性卒中,如果影像上提示为栓塞性(非腔隙)梗死并且经过一系列检查未找到栓子来源,此时这些隐源性卒中称为不明来源栓塞性卒中(embolic strokes of undetermined source,ESUS)。

NEJM:达比加群预防未确定来源栓塞性卒中患者的复发性卒中

由此可见,对于近期未确定来源的栓塞性卒中患者,达比加群在预防复发性卒中方面并不优于阿司匹林。达比加群组的主要出血发生率不高于阿司匹林组,但达比加群组的临床相关非大出血事件更多。

Neurology:未确定来源的栓塞性卒中患者颈动脉斑块与房颤

由此可见,相比于颈动脉粥样硬化斑块的患者,非典型颈动脉斑块的ESUS患者AF检出率较低。

JAHA:左心室射血分数、室壁运动异常与未确定来源栓塞性卒中的关系

由此可见,在整个队列中,LVEF或LV室壁运动异常与ESUS之间不存在关联;然而,在排除任何有同侧颈动脉粥样硬化证据的ESUS患者后,较低的LVEF似乎与ESUS有关。

Baidu
map
Baidu
map
Baidu
map